Log in or Sign up for Free to view tailored content for your specialty!
Therapeutics News
Q&A: Cuts to 2025 physician fee schedule yield ‘catastrophic’ impacts to patient access
The CMS finalized cuts to the 2025 physician fee schedule for the fifth year in a row, prompting an urgent call-to-action from the American Academy of Dermatology. HHS, through the CMS, announced the finalization of the 2025 Medicare Physician Fee Schedule.
Cryomodulation reduces rosacea symptoms
ORLANDO — Patients with rosacea experienced an improvement in symptoms following cryomodulation, according to pilot study results presented at the American Society for Dermatologic Surgery Annual Meeting.
FDA approves Botox Cosmetic for platysma bands
The FDA has approved Botox Cosmetic to temporarily improve the appearance of moderate to severe platysma bands — vertical bands that connect the jaw and neck — in adults, according to a press release from the manufacturer.
Log in or Sign up for Free to view tailored content for your specialty!
Investigators, patients satisfied with RECELL for treatment of vitiligo
ORLANDO — Autologous skin cell suspension using RECELL was an effective and safe treatment for patients with stable vitiligo, according to a presentation at the American Society for Dermatologic Surgery Annual Meeting.
‘Under promise and over deliver’: Speaker highlights consensus on treating acne scars
ORLANDO — A speaker at the American Society for Dermatologic Surgery Annual Meeting highlighted a set of international consensus recommendations for the use of energy-based devices for acne scar treatment.
Organon to acquire Dermavant, Vtama cream in definitive agreement
Organon and Dermavant have entered a definitive agreement in which Organon will acquire Dermavant, according to a press release.
Catch up with top Healio Dermatology news from August
Celebrity news and nutrition stories led Healio Dermatology’s most-read articles in August.
Autologous skin cell suspension transplant efficacious in vitiligo
Autologous skin cell suspension transplantation using a cell harvesting device was shown to be effective and well tolerated in vitiligo treatment, according to a study.
Oral zasocitinib presents high potential as new psoriasis treatment
Zasocitinib, a potent and selective tyrosine kinase 2 inhibitor, safely and effectively cleared psoriasis in a high proportion of patients, according to a study.
FDA clears development of drug to treat cancer therapy-induced skin rash
The FDA has cleared an investigational new drug application for a first-in-human phase 1/2 study of ATR-04 for moderate to severe dermal toxicity from epidermal growth factor receptor inhibitors, Azitra Inc. announced in a press release.
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read
-
Headline News
‘Tide is turning’: STI epidemic shows signs of slowing, CDC says
November 12, 20242 min read -
Headline News
Q&A: Intuitive eating can help people with diabetes improve their relationship with food
November 13, 20246 min read -
Headline News
Teens vape nicotine to help them relax, survey finds
November 12, 20242 min read